tag:blogger.com,1999:blog-2476881389444442972024-03-19T03:48:08.936-07:00My Malignant MelanomaSeanty's experiences with Metastatic Malignant Melanoma.
Part of www.mymalignantmelanoma.com.
Email us direct at help@mymalignantmelanoma.comseantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.comBlogger206125tag:blogger.com,1999:blog-247688138944444297.post-81892903092875905012015-07-23T22:04:00.000-07:002015-07-23T22:04:00.252-07:00New Melanoma BlogThe MIF have a new blog <a href="http://melanomainternational.org/2015/07/melanoma-the-doctor-is-in/">here</a>. The doctor is in, as they say.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-23844873051799660402015-07-15T09:08:00.002-07:002015-07-15T09:09:22.394-07:00BoredomThat thing I thought was nothing in my last post was indeed nothing. Not having cancer is nowhere near as exciting as having it. I don't miss it though.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-78792921162398703112015-05-08T05:57:00.001-07:002015-05-08T05:57:13.257-07:00Excitement!Had my yearly check-up yesterday. There is something, (probably a wart) next to my excision scar, and the dermatologist would like to cut it out and have it checked for MM.<br />
<br />
Can't get too excited about it...seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-88614742660565351762014-07-29T09:08:00.003-07:002014-07-29T09:08:23.093-07:00Don't Feed the TrollI see Cancer Chat are still allowing the notorious cancer board troll "Peter 12" to post silly diet advice on their boards. <a href="http://forum.breastcancercare.org.uk/t5/Living-with-breast-cancer/ERROR-MESSAGE-cooking-HOW-TO-PREVENT-INFECTIONS-READ/td-p/668916">Peter, aka Alex aka Sylvana aka Alain23 aka Ladylady aka Sabina</a> on other cancer boards posts garbled nonsense in a style which suggests they are not a native speaker of English on as many boards as they can.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-8592612112961001532014-07-26T07:30:00.001-07:002015-07-23T22:06:20.415-07:00Nothing To See Here: Taming MMI don't think of melanoma very often nowadays. I'm still NED, and they have so many new drugs for MM now that recurrence / stage 4 MM would be a completely different thing from what it was just a few years ago.<br />
<br />
I am in touch with a number of people around the world who have survived stage 4 for years, and are now NED.<br />
<br />
This didn't used to happen back when I was diagnosed, when you were diagnosed with stage 4 MM you were toast. People seemed to last a few months, and as soon as they had brain mets they lasted weeks. seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0United Kingdom55.378051 -3.4359729999999912.1996745 -86.05316049999999 90 79.18121450000001tag:blogger.com,1999:blog-247688138944444297.post-34495805217164985302013-12-05T03:35:00.002-08:002013-12-26T09:38:59.258-08:00Scansol BoardThe melanoma board run by scansol is no longer being looked after by the company, and appears nowhere on Google. I have been acting as an unpaid moderator against the tidal wave of kitchen spam for some time now, but recently I gave up in the face of the indifference of the owners.<br />
<br />
It is hard to see it so full of spam when it was so useful to me back when I was diagnosed, and it still has posts from JohnDerby, Alison, and others who were helpful to me, but died of MM but I feel a little foolish keeping a forum clean for owners who don't seem to care.<br />
<br />
In any case, <a href="http://melanomainternational.org/">MIF</a> have a far superior forum, kept clean of altie nonsense without any effort on my part. seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-36890346002561727472013-10-11T03:33:00.000-07:002013-10-11T03:33:04.816-07:00Back to NEDAs usual, my ultrasound scan yesterday showed no sign of MM, just some new scarring. They couldn't even find anything to do a fine needle aspiration on, so that's an experience missed out on.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-55477850785887942742013-09-21T08:41:00.003-07:002013-09-21T08:41:50.213-07:00Another Followup, Another LumpSo I had a bit of a lump in my armpit when I had my follow-up in London last week. An ultrasound was promised within a fortnight, but no appointment yet.<br />
<br />
Mild annoyance rather than the panic I would have had five or six mystery lumps ago...seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-56339326594275238772013-09-02T04:12:00.001-07:002013-09-06T00:50:08.528-07:00Bugger Melanoma!: My top tips for hospital stays<a href="http://buggermelanoma.blogspot.com/2012/04/my-top-tips-for-hospital-stays.html?spref=bl">Bugger Melanoma!: My top tips for hospital stays</a>: Bring a laptop/dvd player and plenty to watch for when you're in bed and a portable mp3 player for when you go on exercise walks... <br />
<br />
Have you tried claiming to be rastafarian? They have to bring in caribbean takeaway.... seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-21534532673313417962013-08-09T04:00:00.002-07:002013-08-09T04:01:27.124-07:00Melanoma International Foundation and Other Melanoma Boards<a href="http://melanomainternational.org/">The MIF site </a>has grown into the best MM site on the internet now. Though US based, they have moderated out all of the altie nonsense and bible-bashing which you used to see on the MPIP site. I actually more than once saw declared paid employees of Mexican quack clinics being allowed to promote their worthless "treatments" with lies on MPIP. Not helpful.<br />
<br />
I'm afraid to say that the Scansol Melanoma Board isn't being very well looked after by its owners nowadays. I'm deleting half a dozen (mostly kitchen) spammers per day for them, but I can't get a reply out of the web admins to my requests to tighten up on new accounts.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-77954754229904555272013-07-28T22:36:00.001-07:002013-07-29T01:11:01.665-07:00Stage 4 SurvivorI received a communication from a blogger who has survived stage 4 MM since 2009, (an increasingly common class of people since the new drugs came in).<span style="font-family: Georgia; font-size: small; text-indent: 0px; word-spacing: 0px;"> </span><br />
<br />
<blockquote class="tr_bq">
<span style="font-family: Georgia; font-size: small; text-indent: 0px; word-spacing: 0px;">"</span><span style="font-family: Georgia; font-size: small; text-indent: 0px; word-spacing: 0px;">I wanted to
add your link to my page.. <a href="http://www.survivingmelanoma.com/">www.survivingmelanoma.com</a>. I am
a stage 4 melanoma survivor and was given 6-9 months in 2009 June. I have been
NED for over 3 years and 4 months.</span></blockquote>
<blockquote class="tr_bq">
<span style="font-family: Georgia; font-size: small; text-indent: 0px; word-spacing: 0px;">I
need to add international links because I have received several e-mail questions
about treatment centers in Europe and elsewhere for clinical trials. Would you
have any resources you would share? We have <a href="http://www.cancer.gov/">www.cancer.gov</a> to look up clinical trials.</span><span style="font-family: Georgia; font-size: small; text-indent: 0px; word-spacing: 0px;"> </span><br />
<br />
<span style="font-family: Georgia; font-size: small; text-indent: 0px; word-spacing: 0px;">I also had a question..how many stages of melanoma do the medical society
use over there...we only have 0, 1,2,3,4 and I noticed someone posted
“stage 5”...here in the US we don’t have a stage
5"</span></blockquote>
<br />
Last things first, <a href="http://mymalignantmelanoma.blogspot.co.uk/2013/05/checking-in.html">the post about stage V MM</a> was missing an "I", it was supposed to be stage IV. If there were a stage which was classed as V, there would usually only be one thing you could do, to quote <a href="http://www.imdb.com/character/ch0003789/quotes">Miracle Max</a>: "Go through his clothes and look for loose change". Apologies for this, and for my gallows humour to anyone who doesn't share it.<br />
<br />
As far as resources are concerned, I believe that the best place to look at them moment for links is the MIF forum <a href="http://forum.melanomainternational.org/mif/">here</a>.The MRF/MPIP forum allows posting of harmful nonsense about alternative medicine, and what is effectively advertising for Mexican quack clinics and I would strongly disrecommend it. <br />
<br />
I am unaware of any private clinics in the UK which are as good as the NHS centres of excellence: Christies in Manchester and The Royal Marsden in London amongst other places. NHS treatment away from these centres of excellence can be poor, and the new drugs may not be offered. Before the new drugs, surviving Stage 4 for a year was very rare indeed.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-49239014516130639452013-07-23T23:43:00.004-07:002013-07-23T23:43:55.433-07:00Blue Sky Day : YOU62Blue Sky Day by YOU62 has just been listed on i tunes- presumably
amazon will follow shortly. If you buy, watch out as there are several
songs with the same name by different artists.<br /><br />There are also a
limited number of hard copies of the CD for those who prefer the old
ways- £3- per copy (plus £1- for postage). Let me know if you want one.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-63942846726905253932013-07-01T03:19:00.002-07:002013-07-01T03:28:13.922-07:00YOU 62 Single<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiajttQp8QreQ6O0hFXVsLjEEvEzMkZxVob5BdyAlBe9VomJDcXqlFe3vQAnnu81y75LGMZ4X2pSr6TkSAocyHou68068-j5-Zbiv4gkfwoJKLSSUGCjYOZXnhdUxlbyqrL8_wYKOqlMMQl/s1600/Blue+sky+day+poster+final+(reviewed2)jpeg+Borg.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiajttQp8QreQ6O0hFXVsLjEEvEzMkZxVob5BdyAlBe9VomJDcXqlFe3vQAnnu81y75LGMZ4X2pSr6TkSAocyHou68068-j5-Zbiv4gkfwoJKLSSUGCjYOZXnhdUxlbyqrL8_wYKOqlMMQl/s640/Blue+sky+day+poster+final+(reviewed2)jpeg+Borg.jpg" width="451" /></a></div>
<br />
Christie Hospital's Young Oncology Unit has a music therapy unit attached, which is where the band met. Peter Garner, a young stage 4 MM patient (<a href="http://mymalignantmelanoma.com/Melanoma_Stories_Sarah%27s_Story.html">see Sarah's Story</a>) has been nicknamed Borg for years, but
now he is wheelchair bound he adopted the name Borg Ironsides.<br />
<br />
They
have produced a single, which will go on sale on 21st July, and is
available to download on Amazon and Itunes. There will also (hopefully )
be CDs available, but funding needs to be arranged before they can be
made.<br />
<br />
It has already been played on ITV and BBC, and a full radio
interview is available <a href="http://www.youtube.com/watch?v=c02vAhmy91Q">here</a> The single can be heard at 5.36 of that interview., and there are other YouTube clips with videos.<br />
<br />
All
proceeds will go to the Teenage
Cancer Trust- aimed specifically at cancer patients between the ages of
16 and 24. Its aims are to improve the quality of life for them, both
during and after treatment. I know the music unit has been a godsend to
Peter's family.<br />
<br />
I
would be most grateful if you could publicise this as much as possible, and buy the single on release! There will be a video to go with it..
The aim is to raise money for a larger music unit. The current one is a
little cramped to say the least.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-78384691995701518932013-06-21T01:56:00.001-07:002013-06-21T01:56:51.338-07:00Ben's StoryThere's a new melanoma story in the In Memoriam section: <a href="http://www.mymalignantmelanoma.com/In_%20Memoriam_Ben%27s_Story.html">Ben's story</a>seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-11486621599428482752013-06-18T01:28:00.002-07:002013-06-18T01:36:11.532-07:00Hottest ProspectsI'm told that the hottest new prospects for MM treatment at last week's ASCO conference were thought to be:<br />
<br />
1. Combination therapy of BRAF and MEK inhibitors from GSK (Tafinlar/dabrafenib plus Mekinist /trametinib) - headline: resistance only develops after 9 instead of 6 months<br />
<div class="-cx-PRIVATE-webMessengerMessageGroup__messageanddebug clearfix">
<div class="-cx-PRIVATE-webMessengerMessageGroup__debug">
<span class="-cx-PRIVATE-webMessengerMessageGroup__status"></span></div>
</div>
<div class="-cx-PRIVATE-webMessengerMessageGroup__messageanddebug clearfix">
<div class="-cx-PRIVATE-webMessengerMessageGroup__message direction_ltr">
<br />
2. Merck anti-PD1(Lambrolizumab) - headline: good initial response rate, relatively mild side-effects </div>
<div class="-cx-PRIVATE-webMessengerMessageGroup__debug">
<span class="-cx-PRIVATE-webMessengerMessageGroup__status"></span></div>
</div>
<div class="-cx-PRIVATE-webMessengerMessageGroup__messageanddebug clearfix">
<div class="-cx-PRIVATE-webMessengerMessageGroup__message direction_ltr">
<br />
3. BMS anti-PD1 (MDX-1106) plus Ipilimumab / Yervoy - headline: good results although 50% had nasty side effects<br />
<h2 class="pressHeader">
</h2>
</div>
</div>
seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-86193006113364313532013-06-12T07:54:00.004-07:002013-06-14T08:24:17.710-07:00Treatments Update<!--[if gte mso 9]><xml>
<o:DocumentProperties>
<o:Version>14.00</o:Version>
</o:DocumentProperties>
<o:OfficeDocumentSettings>
<o:AllowPNG/>
</o:OfficeDocumentSettings>
</xml><![endif]--><br />
<!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves/>
<w:TrackFormatting/>
<w:PunctuationKerning/>
<w:ValidateAgainstSchemas/>
<w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
<w:IgnoreMixedContent>false</w:IgnoreMixedContent>
<w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
<w:DoNotPromoteQF/>
<w:LidThemeOther>EN-GB</w:LidThemeOther>
<w:LidThemeAsian>X-NONE</w:LidThemeAsian>
<w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
<w:Compatibility>
<w:BreakWrappedTables/>
<w:SnapToGridInCell/>
<w:WrapTextWithPunct/>
<w:UseAsianBreakRules/>
<w:DontGrowAutofit/>
<w:SplitPgBreakAndParaMark/>
<w:EnableOpenTypeKerning/>
<w:DontFlipMirrorIndents/>
<w:OverrideTableStyleHps/>
</w:Compatibility>
<m:mathPr>
<m:mathFont m:val="Cambria Math"/>
<m:brkBin m:val="before"/>
<m:brkBinSub m:val="--"/>
<m:smallFrac m:val="off"/>
<m:dispDef/>
<m:lMargin m:val="0"/>
<m:rMargin m:val="0"/>
<m:defJc m:val="centerGroup"/>
<m:wrapIndent m:val="1440"/>
<m:intLim m:val="subSup"/>
<m:naryLim m:val="undOvr"/>
</m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
<w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267">
<w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
<w:LsdException Locked="false" Priority="39" Name="toc 1"/>
<w:LsdException Locked="false" Priority="39" Name="toc 2"/>
<w:LsdException Locked="false" Priority="39" Name="toc 3"/>
<w:LsdException Locked="false" Priority="39" Name="toc 4"/>
<w:LsdException Locked="false" Priority="39" Name="toc 5"/>
<w:LsdException Locked="false" Priority="39" Name="toc 6"/>
<w:LsdException Locked="false" Priority="39" Name="toc 7"/>
<w:LsdException Locked="false" Priority="39" Name="toc 8"/>
<w:LsdException Locked="false" Priority="39" Name="toc 9"/>
<w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
<w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/>
<w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
<w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
<w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
<w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
<w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
<w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
<w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
<w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
<w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
<w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
<w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
<w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
<w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
<w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
<w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
<w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
</w:LatentStyles>
</xml><![endif]--><!--[if gte mso 10]>
<style>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:"";
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
mso-para-margin-top:0cm;
mso-para-margin-right:0cm;
mso-para-margin-bottom:10.0pt;
mso-para-margin-left:0cm;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;
mso-fareast-language:EN-US;}
</style>
<![endif]-->
<br />
<div class="MsoNormal">
<span style="mso-bidi-font-weight: normal;">There are so many new drugs coming through that it's hard to keep up. Here's a summary of drugs and their targets (mostly simplified from Wikipedia entries)<u>.</u> Let me know if I've missed any, I know there are lots more under these target headings which just have codes for names at present.</span><span style="mso-bidi-font-weight: normal;"><u><br /></u></span></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><u>TARGET: BRAF</u></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
BRAF is a human gene that makes a protein called B-Raf. The
B-Raf protein is involved in sending signals inside cells, which are involved
in directing cell growth. In 2002, it was shown to be faulty (mutated) in human
cancers. Drugs that treat cancers driven by BRAF have been developed. Two of
these drugs, vemurafenib and dabrafenib are approved by the US FDA for treatment of
late-stage melanoma.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Dabrafenib /Tafinlar </b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Dabrafenib acts as an inhibitor of B-Raf. Dabrafenib has
clinical activity with a manageable safety profile in clinical trials of phase
1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma. It was
approved for use against melanoma by the FDA in May
30th, 2013.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Vemurafenib /
Zelboraf</b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
is a B-Raf enzyme inhibitor developed for the treatment of
late-stage melanoma. Vemurafenib received FDA approval for the treatment of
late-stage melanoma on August 17, 2011, Health Canada approval on February 15,
2012 and on February 20, 2012, the European Commission approved vemurafenib as
a monotherapy for the treatment of adult patients with BRAF V600 mutation
positive unresectable or metastatic melanoma, the most aggressive form of skin
cancer.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">LGX818</b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
A drug by Novartis disclosed at the
spring 2013 American Chemical Society meeting in New Orleans to treat melanoma
with a V600E mutation in the B-RAF kinase which it inhibits. The drug is
currently undergoing Phase II trials.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><u>TARGET: MEK</u></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
A MEK inhibitor is a chemical or drug that inhibits a biochemical
switch upstream of the gene which produces B-Raf, which is often overactive in BRAF-mutated
melanoma. Hence MEK inhibitors can both work as standalone drugs, and increase the effectiveness of BRAF drugs.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Trametinib /Mekinist</b>
</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
is a MEK inhibitor drug with anti-cancer activity. It
inhibits MEK1 and MEK2. In May 2013, trametinib was
approved by the FDA for the treatment of melanoma.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><u>TARGET:</u><u>CTLA</u><u>-4</u></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Cytotoxic T lymphocytes (CTLs) can recognize and destroy
cancer cells. However, there is also an inhibitory mechanism via a gene called
CTLA-4 that interrupts this destruction. CTLA-4 inhibitors turn off this mechanism and allows CTLs to continue to destroy cancer cells.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Ipilimumab /Yervoy</b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Ipilimumab was approved by the FDA in March 2011 to treat
patients with late-stage melanoma that has spread or cannot be removed by surgery.
On February 1, 2012, Health Canada approved ipilimumab for "treatment of
unresectable or metastatic melanoma in patients who have failed or do not
tolerate other systemic therapy for advanced disease." Additionally
Ipilimumab was approved in both the UK and European Union (EU), for second line
treatment of metastatic melanoma, November 2012.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Zanolimumab</b><b>/ HuMax-CD4</b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Action as ipilimumab. The drug is currently undergoing Phase
II trials.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><u>TARGET: PD-1</u></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Researchers have shown that several tumour types are able to
hide in plain sight by establishing a "molecular camouflage" that
deceives the body's immune system into thinking they are normal and therefore
allow them to grow unchecked. By utilizing the PD-1 pathway, a tumour cell can
prevent the activation of T-cells and therefore may block a key step that
triggers the immune system. Drugs targeting this pathway can remove the cells "camouflage", allowing the body to destroy them. </div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Lambrolizumab / MK-3475</b>
</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
is an antibody drug in development by Merck that targets the PD-1
receptor. The drug is intended for use in treating metastatic melanoma. Lambrolizumab
is being studied in multiple cancer types including melanoma.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Nivolumab</b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Nivolumab is an antibody drug which acts on the PD1 receptor. A Phase 1 clinical trial tested nivolumab at
doses ranging from 0.1 to 10.0 mg per kilogram of body weight, every 2 weeks.
Response was assessed after each 8-week treatment cycle, and were evaluable for
236 of 296 patients. Study authors concluded that:"Anti-PD-1 antibody
produced objective responses in approximately one in four to one in five
patients with non–small-cell lung cancer, melanoma, or renal-cell cancer; the
adverse-event profile does not appear to preclude its use." Phase III
clinical trials of nivolumab are recruiting in the US and EU.<br />
<br />
<u><b>TARGET: Other</b></u><br />
<br />
<b>Allovectin-7</b><br />
<br />
is an immune booster. In 1999, FDA granted Allovectin-7 orphan drug designation for the treatment of invasive and metastatic melanoma.<br />
<br />
<b>Talimogene laherparepvec/ T-VEC</b><br />
<br />
Talimogene laherparepvec, often simply called "T-VEC" is a cancer-killing (oncolytic) virus currently being studied for the treatment of melanoma and other advanced cancers. The drug was initially developed by BioVex, Inc. under the name OncoVEX GM-CSF until it was acquired by Amgen in 2011. With the announcement of positive results in March 2013, T-VEC is the first oncolytic virus to be proven effective in a Phase III clinical trial<br />
<br />
I have updated my pages on <a href="http://www.mymalignantmelanoma.com/Melanoma_Questions_what_experimental_treatments_are_there.html">experimental</a> and <a href="http://www.mymalignantmelanoma.com/Melanoma_Questions_what_established_treatments_are_there.html">established</a> drugs to reflect the new possibilities. It hasn't been necessary to update my <a href="http://www.mymalignantmelanoma.com/Melanoma_Questions_alternative%20_treatments.html">alternative medicine</a> page - it still doesn't work.</div>
seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-84093289461671096432013-06-11T06:31:00.001-07:002013-06-11T06:33:45.137-07:00Update : PD-1 drugsI'm told that UK trials of the new and <a href="http://mymalignantmelanoma.blogspot.co.uk/2013/06/new-class-of-melanoma-drugs-may-be.html">highly promising PD1 antibodies</a> for treatment-naive patients with advanced melanoma start in the next few weeks at Royal Marsden, Manchester and Southampton. seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-6309146193771995362013-06-09T11:45:00.000-07:002013-06-09T11:46:24.095-07:00New class of melanoma drugs may be curativeSaw in the New Scientist today that there are a number of really promising new drugs for MM coming through: <a href="http://www.nejm.org/doi/full/10.1056/NEJMoa1305133">Lambrolizumab</a> and <a href="http://www.news-medical.net/news/20130604/Data-from-Nivolumab-phase-I-study-in-patients-with-kidney-cancer-to-be-presented-at-ASCO-2013.aspx">Nivolumab</a>, which both work on the PD-1 receptor, and a so far unnamed drug which works on another receptor.<br />
<br />
All give great reductions in tumour volume, and there all in all cases apparent complete cures. They all work by rebooting the immune system, in just the same way as quack diets claim to do, but actually don't.<br />
<br />
In other news, it seems that <a href="http://www.cancerresearchuk.org/cancer-info/news/archive/pressrelease/2013-06-07-DNA-sequencing-reveals-mucosal-melanoma-bullseye?rss=true">mucosal melanoma is really a different disease</a> from cutaneous melanoma.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-76835439788136700912013-05-30T03:25:00.004-07:002013-07-28T22:37:00.418-07:00Checking InPrompted by an email from Mark in the US, a long term Stage IV melanoma survivor (thanks to Zelboraf) who has been writing to me for a while, I thought I'd update the blog.<br />
<br />
I've got a new job in a local University, which I have being doing alongside most of my old job, so I have been wildly busy for the last couple of years.<br />
<br />
I've dropped most of my melanoma care, as nothing has shown despite a number of scares which I have related on here. I'm going to a yearly appointment which I have kept on at the London hospital which gave me my SNB in Autumn.<br />
<br />
My armpit where they removed the lymph modes feels a bit swollen recently, but I've though that before and its turned out to be nothing. Its hard to remember where the lumps from scar tissue are supposed to be, and at worst it's probably a seroma or lymphoedema.<br />
<br />
I'm considering going to the docs if it doesn't sort itself out soon, but I'm not as panicky now after all the scares I've had, especially now there are some drugs and other treatments which can help MM patients. <br />
<br />
I got a message from "<a href="http://www.thatslife.co.uk/">That's Life</a>" magazine recently. If you are a woman who'd like them to feature your MM story, contact me (apparently the only way men can feature in That Life is on the <a href="http://www.thatslife.co.uk/getintouch/is-your-man-daft">Aren't Men Daft</a> page. They are willing to pay for your story. Follow the first link above to get an idea of the line they are likely to take. seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-81915606337207599432013-01-12T08:18:00.002-08:002013-01-12T08:18:26.613-08:00Kitchen Spammers:SolidWoodKitchens and The Kitchen GangsterOver on the <a href="http://www.scansol.co.uk/forum/viewtopic.php?f=1&t=1985">melanoma patients board</a>, many of the new people signing up on this site are
spammers employed by kitchen companies. I ban at least one a day,
sometimes six or seven. <br /><br />The main one is "solid wood kitchens" who have lots of websites, for example <a class="postlink" href="http://www.solidwoodkitchens.com/">http://www.solidwoodkitchens.com</a>
- phone number 01512 032 895. I phoned them to ask them to stop, but if
anything the volume of spam went up. A look at the web shows that this
is usual. There is no point in calling to complain to these people. <br /><br />However, the person registered as responsible for originally registering the the domain is:<br /><br />Aftab Ali<br />Trading as:<br />Sizzle Media Ltd<br />Evans Business Centre<br />Rochdale<br />Lancs<br />OL12 6XB<br />United Kingdom<br /><a class="postlink" href="http://www.sizzlemedia.co.uk/">http://www.sizzlemedia.co.uk</a><br /><br />Elsewhere
on the 'net he admits he set it up but takes no responsibility, blaming
search engine promotion companies overseas. Mr Ali claims that the real
client is: <br /><br />Laura Digweed<br />41 Duke Avenue<br />Manchester<br />Lancashire<br />OL12 7HJ<br />United Kingdom <br /><br />But sometimes Mr Ali has been shown as the registrant at this address - all very confusing.<br /><br />The up-to date named contact is however M Leak - same Duke Avenue address. His website is at <a class="postlink" href="http://matthewleak.co.uk/">http://matthewleak.co.uk</a>.
(If I were as rubbish as he seems to be at web design and wanted to
sell myself as a web designer I'd have got someone else to design my
personal site) <br /><br />There are contact details if you follow the link - feel free to let him know how you feel about his activities.<br /><br />Then
there are the companies with various website and company names with
phone numbers 01616694780 and 01416116995. Whilst they have similar
tactics, they seem to be spammer/scammers of a different calibre
entirely.<br />
<br />
These numbers have been linked to "The Kitchen Gangster" <a class="postlink" href="http://en.wikipedia.org/wiki/Vance_Miller">Vance Miller</a>,
subject of a number of consumer TV, trading standards, and police
investigations. He has convictions for kidnapping and affray, and is
currently banned from being a UK company director.<br />
<br />
A judge described him
as “intelligent, cunning, manipulative but above all arrogant”.
Probably not worth phoning him up then - best stick with the chumps from
solid wood kitchens.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com1tag:blogger.com,1999:blog-247688138944444297.post-14480648932101984612013-01-01T06:21:00.000-08:002013-01-01T22:24:21.072-08:00Rory's Story Update<a href="http://mymalignantmelanoma.com/Melanoma_Stories_Rory%27s_Story.html">Rory's Story Update</a>. A little late due to computer problems....seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-20687285701371615232013-01-01T06:19:00.004-08:002013-01-01T22:22:06.394-08:00A Message from Stupidsville<br />
<br />
I received the following message from someone whose website describes her as a home-schooling mother:<br />
<br />
<i>"I was reading on the American Cancer Society about alkalizing and
cancer. They stated that it was found to be of benefit to alkalize your
body to inhibit cancer. My father in law started doing it 10 years ago
and is 8 years past his death diagnoses for Multiple Myleloma.
Why do you say it does not work? on <a href="http://mymalignantmelanoma.blogspot.com/2009/01/tullio-simoncini.html" target="_blank">Tullio Simoncini"</a></i><br />
<br />
I get lots of these. I never publish them as comments because they have links in them to quack sites. This one is however extra-stupid. None of those vague and hard to disprove claims for this home-educator. I am not in a position to verify their anecdote, but I can fact-check the rest of it.<br />
<br />
So does the American cancer society recommend alkalising your body? <a href="http://onlinelibrary.wiley.com/doi/10.3322/caac.20140/full">Here are their diet and exercise guidelines.</a> No mention of alkaline diet there, or anywhere on their website. The internet is however full of quacks and their dupes claiming the ACS as the primary source for this nonsense - but it just isn't true.<br />
<br />
In fact I didn't really need to check, as it can't be true, because the ACS employs scientists and doctors who know that there is no diet which can alkalise the body. <a href="http://www.123hjemmeside.dk/cancer_is_not_a_fungus">Alkaline Diet</a> is nonsense, and Tullio Simoncini is a convicted fraudster, barred from practising medicine after his conviction for the manslaughter of a patient in his "care". <br />
<br />
There is no mention anywhere in the publications of the ACS or any other reputable body of a diet which can reverse
cancer, these are the usual "healthy eating" guidelines intended to
reduce the risk of cancer. There is in fact no diet known or even suspected of being able
to reverse cancer of any kind, though the web is full of such
nonsensical claims.<br />
<br />
Alkaline, Budwig, Gerson, and the rest of the quack diets are promoted by scum who prey on cancer patients, and supported by muddle-headed fools who think we should treat all opinions as equal, whatever the supporting evidence.<br />
<br />
Even after bottom-feeding vermin like Simoncini have been struck off, convicted as killers and fraudsters, morons stick up for them.<br />
<br />
Why do I say it does not work? Leaving aside for a moment the fact that I
am not obliged to disprove false medical claims, but their proponents
to prove them - t<a href="http://www.123hjemmeside.dk/cancer_is_not_a_fungus/21160738">ry this list of a few of Simoncini's victims.</a> It includes details of how much this killer charges the victims of his fraud.<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://t3.gstatic.com/images?q=tbn:ANd9GcSmqHtV7IS-jScjqHTDQUc04Rdenpajm7In0z3G2dXKb8dGhlIoFKava4_5" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="136" id="il_fi" src="http://t3.gstatic.com/images?q=tbn:ANd9GcSmqHtV7IS-jScjqHTDQUc04Rdenpajm7In0z3G2dXKb8dGhlIoFKava4_5" style="padding-bottom: 8px; padding-right: 30px; padding-top: 8px;" width="369" /></a></div>
<br />seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-66530476237678888962012-12-11T08:06:00.000-08:002013-01-01T22:25:37.068-08:00Sarah's Story Update<br />
There is an update to Sarah's story of her son's continuing battle with stage 4 MM <a href="http://mymalignantmelanoma.com/Melanoma_Stories_Sarah%27s_Story.html">here</a>.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-53405967186746279942012-11-09T01:20:00.000-08:002012-11-09T01:20:02.724-08:00How things changeSo the lump is a hernia, and the new mole on my foot only referred for dermatologist to have a look at because of my history. No worries, I'm used to this stuff now.seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0tag:blogger.com,1999:blog-247688138944444297.post-78280907208245234892012-11-08T21:40:00.001-08:002012-11-08T21:42:33.487-08:00Blip<div dir="ltr" style="text-align: left;" trbidi="on">
Funny mole on the sole of my foot and funny lump next to my navel, so off to the docs this morning, hopefully for reassurance.<br />
<br />
Shrugged off the mole, there have been so many odd patches of skin which turned out to be nothing which only hyper-vigilant former skin cancer patients would give a send though to now to worry much about things like that.<br />
<br />
Lump on the belly more of a novelty. I'll be glad to be reassured.</div>
seantyhttp://www.blogger.com/profile/02182909963199750202noreply@blogger.com0